Budama-Kilinc Yasemin, Cakir-Koc Rabia, Kecel-Gunduz Serda, Kokcu Yagmur, Bicak Bilge, Mutlu Hande, E Ozel Aysen
Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey.
Physics Department, Istanbul University, Istanbul, Turkey.
PeerJ. 2018 Jan 30;6:e4270. doi: 10.7717/peerj.4270. eCollection 2018.
-acetylcarnosine (NAC), a dipeptide with powerful antioxidant properties that is extensively used as a pharmaceutical prodrug for the treatment of cataract and acute gastric disease, was investigated by molecular dynamics with the GROMACS program in order to understand the solvent effect on peptide conformation of the peptide molecule used as a component of a drug and which presents substantial information on where drug molecules bind and how they exert their effects. Besides, molecular docking simulation was performed by using the AutoDock Vina program which identify the kind of interaction between the drug and proteins. A delivery system based on poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) loaded with NAC (NAC-PLGA-NPs) for the treatment of cataract was prepared for the first time in this study in order to enhance drug bioavailability and biocompatibility. The objective of this work was to prepare and evaluate the structural formulation, characterization, and cytotoxicity studies of NAC-loaded NPs based on PLGA for cataract treatment.
PLGA and NAC-loaded PLGA NPs were prepared using the double emulsion (w/o/w) method, and characterizations of the NPs were carried out with UV-Vis spectrometer to determine drug concentration, the Zeta-sizer system to analyze size and zeta potential, FTIR spectrometer to determine the incorporation of drug and PLGA, and TEM analysis for morphological evaluation.
NAC-loaded PLGA NPs were successfully obtained according to UV-Vis and FTIR spectroscopy, Zeta-sizer system. And it was clearly observed from the TEM analysis that the peptide-loaded NPs had spherical and non-aggregated morphology. Also, the NPs had low toxicity at lower concentrations, and toxicity was augmented by increasing the concentration of the drug.
The NAC molecule, which has been investigated as a drug molecule due to its antioxidant and oxidative stress-reducing properties, especially in cataract treatment, was encapsulated with a PLGA polymer in order to increase drug bioavailability. This study may contribute to the design of drugs for cataract treatment with better reactivity and stability.
N - 乙酰肌肽(NAC)是一种具有强大抗氧化特性的二肽,被广泛用作治疗白内障和急性胃病的药物前体。本研究使用GROMACS程序通过分子动力学对其进行研究,以了解溶剂对用作药物成分的肽分子构象的影响,该肽分子能提供有关药物分子结合位置及作用方式的大量信息。此外,使用AutoDock Vina程序进行分子对接模拟,以确定药物与蛋白质之间的相互作用类型。本研究首次制备了基于聚乳酸 - 乙醇酸共聚物(PLGA)纳米颗粒(NPs)负载NAC(NAC - PLGA - NPs)的给药系统,用于治疗白内障,以提高药物的生物利用度和生物相容性。本工作的目的是制备并评估基于PLGA负载NAC的纳米颗粒用于白内障治疗的结构配方、表征及细胞毒性研究。
采用双乳液(w/o/w)法制备PLGA和负载NAC的PLGA纳米颗粒,并用紫外 - 可见光谱仪测定药物浓度、Zeta粒度分析仪分析粒径和zeta电位、傅里叶变换红外光谱仪测定药物与PLGA的结合情况,以及用透射电子显微镜(TEM)分析进行形态学评估。
根据紫外 - 可见光谱和傅里叶变换红外光谱、Zeta粒度分析仪系统,成功获得了负载NAC的PLGA纳米颗粒。从透射电子显微镜分析中可以清楚地观察到,负载肽的纳米颗粒具有球形且无聚集的形态。此外,纳米颗粒在较低浓度下毒性较低,且随着药物浓度的增加毒性增强。
由于NAC分子具有抗氧化和减轻氧化应激的特性,特别是在白内障治疗中作为药物分子进行了研究,为提高药物生物利用度,用PLGA聚合物对其进行了封装。本研究可能有助于设计出具有更好反应性和稳定性的白内障治疗药物。